Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (SHA:603707)

China flag China · Delayed Price · Currency is CNY
10.97
+0.08 (0.73%)
Jul 11, 2025, 2:45 PM CST
-3.94%
Market Cap 17.71B
Revenue (ttm) 3.80B
Net Income (ttm) 733.67M
Shares Out 1.62B
EPS (ttm) 0.44
PE Ratio 24.99
Forward PE 14.81
Dividend 0.10 (0.91%)
Ex-Dividend Date Jun 5, 2025
Volume 17,611,873
Average Volume 11,281,656
Open 10.89
Previous Close 10.89
Day's Range 10.89 - 11.11
52-Week Range 10.12 - 16.01
Beta 0.59
RSI 47.00
Earnings Date Aug 29, 2025

About SHA:603707

Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of drugs and APIs in China. The company provides heparin sodium, enoxaparin sodium, dalteparin sodium, nadroparin calcium, atracurium, cisatracurium, fulvestrant, doxercalciferol, milrinone lactate, fondaparinux sodium, phenylephrine, gemcitabine, levoleucovorin, carboplatin, cytarabine, bleomycin, topotecan hydrochloride, bendamustine HCL, bortezomib, clofarabine, busulfan, dactinomycin, azacitidine, mycophenolate mofetil, tige... [Read more]

Sector Healthcare
Founded 2000
Employees 1,360
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603707
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.